Page last updated: 2024-11-07

cephamycin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cephamycin C: produced from O-carbamoyldeacetylcephalosporin in C by cell-free extracts of Streptomyces clavuligerus; RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cephamycin C : One of three naturally occurring cephamycin antibiotics, differing from the A and B forms in its carbamoyloxymethyl substituent at C-3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123731
MeSH IDM0083700

Synonyms (9)

Synonym
nsc179170
nsc-179170
38429-35-5
cephamycin c
5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((5-amino-5-carboxy-1-oxopentyl)amino)-7-methoxy-8-oxo-
7-[(5-amino-5-carboxypentanoyl)amino]-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
DTXSID301100850
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[(5-amino-5-carboxy-1-oxopentyl)amino]-7-methoxy-8-oxo-
AKOS040748105

Research Excerpts

Overview

Cephamycin C (CepC) is a beta-lactam antibiotic that belongs to the cephalosporin class of drugs. It is an extracellular broad spectrum beta- lactam antibiotics produced by Streptomyces clavuligerus, S.

ExcerptReferenceRelevance
"Cephamycin C (CepC) is a β-lactam antibiotic that belongs to the cephalosporin class of drugs. "( Kinetic study on cephamycin C degradation.
Barboza, M; Brites, LM; Oliveira, LM, 2013
)
2.17
"Cephamycin C is an extracellular broad spectrum beta-lactam antibiotic produced by Streptomyces clavuligerus, S. "( Production of cephamycin C by Streptomyces clavuligerus NT4 using solid-state fermentation.
Bussari, B; Saudagar, PS; Shaligram, NS; Singhal, RS; Survase, SA, 2008
)
2.15
"Cephamycin C is a beta-lactam antibiotic that has broad gram-negative activity and is resistant to degradation by beta-lactamases and safe for use in animals. "( Cephamycin C treatment of induced enterotoxigenic colibacillosis (scours) in calves and piglets.
Jacks, TM; Judith, FR; Miller, BM; Schleim, KD, 1980
)
3.15

Compound-Compound Interactions

ExcerptReferenceRelevance
" Lysine combined with cadaverine influenced production positively, but only at low lysine concentrations."( Enhancing effect of lysine combined with other compounds on cephamycin C production in Streptomyces clavuligerus.
Araujo, ML; Cavallieri, AP; Leite, CA, 2013
)
0.63
"This study demonstrated that different combinations of lysine with diamines or lysine with alpha-aminoadipic acid engender significant differences with respect to antibiotic volumetric production, with emphasis on the benefits observed for lysine combined with alpha-aminoadipic acid or 1,3-diaminopropane."( Enhancing effect of lysine combined with other compounds on cephamycin C production in Streptomyces clavuligerus.
Araujo, ML; Cavallieri, AP; Leite, CA, 2013
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (15.94)18.7374
1990's18 (26.09)18.2507
2000's27 (39.13)29.6817
2010's12 (17.39)24.3611
2020's1 (1.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.62 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other71 (98.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]